摘要
目的 研究血清乳酸脱氢酶与非霍奇金淋巴瘤分期、治疗及预后的关系。方法 检测 110例非霍奇金淋巴瘤患者血清乳酸脱氢酶水平。结果 治疗前Ⅰ期 +Ⅱ期患者血清乳酸脱氢酶异常增高为 42 9% (2 1/4 9) ,Ⅲ期 +Ⅳ期患者血清乳酸脱氢酶异常增高为 64 8% (4 6/71) ,以Ⅲ期 +Ⅳ期患者血清乳酸脱氢酶异常增高为普遍 (P <0 0 5 )。结论 血清乳酸脱氢酶水平与非霍奇金淋巴瘤分期及生存期有关 ,与治疗无关 ,可作为预测非霍奇金淋巴瘤分期及生存期的重要因素。
Objective To study the serum level of lactic dehydrogenase in non-Hodgkin's lymphoma and their relations with Ann Arbor stage,treatent and prognosis.Methods The serum level of lactic dehydrogenase was measured in 110 cases of patients with non-Hodgkin's lymphoma.Results The pretreatment level of lactic dehydrogenase was abnormally increased in Ⅰ+Ⅱ patients were 42.9%(21/49),and in Ⅲ+Ⅳ patients were 64.8%(46/71),So the increaseing of the level of lactic dehydrogenase in Ⅲ+Ⅳ patients took more importance.Conclusions The serum level of lactic dehydrogenace in non-Hodgkin's lymphoma was related to Ann Arbor stage and prognosis,and have nothing to do with treatment and the lactic dehydrogenase level may be looked on as an important factor for predicting Ann Arbor stage,survival issue of non-Hodgkin's lymphoma.
出处
《河南肿瘤学杂志》
2003年第5期339-340,共2页
Henan Journal of Oncology
